[The effectiveness of the pimafucin 100 mg pill for intravaginal treatment of vaginal candidiasis]

Ginekol Pol. 2000 Jan;71(1):26-33.
[Article in Polish]

Abstract

The aim of this multicentre prospective study was assessing the effectiveness of intravaginal treatment of vaginal candidiasis with Pimafucin 100 mg ovule. Success was obtained among 81% pregnant and 86% nonpregnant women. The negative predictive factors were intensive patients complains: pruritus or soreness.

Publication types

  • Clinical Trial
  • English Abstract
  • Multicenter Study

MeSH terms

  • Administration, Intravaginal
  • Adolescent
  • Adult
  • Antifungal Agents / therapeutic use*
  • Candidiasis, Vulvovaginal / diagnosis
  • Candidiasis, Vulvovaginal / drug therapy*
  • Female
  • Humans
  • Middle Aged
  • Natamycin / therapeutic use*
  • Predictive Value of Tests
  • Pregnancy
  • Prospective Studies
  • Treatment Outcome

Substances

  • Antifungal Agents
  • Natamycin